Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biomed Research International|October 14, 2014
MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesAlessio Cannistraci, Anna Laura Di Pace, Ruggero De Maria, et al.
Frontiers in Immunology|March 8, 2021
Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCTNicola Tumino, Anna Laura Di Pace, Francesca Besi, et al.
Cancers|March 18, 2020
Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor In Exosome-Mediated Cytotoxicity Against TumorAnna Laura Di Pace, Nicola Tumino, Francesca Besi, et al.
Oncoimmunology|June 12, 2023
MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cellsAnna Laura Di Pace, Andrea Pelosi, Piera Filomena Fiore, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2022
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancersPiera Filomena Fiore, Anna Laura Di Pace, Libenzio Adrian Conti, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 8, 2011
Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cellsArturo Giordano, Simona Romano, Mario Monaco, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2020
Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cellsLinda Quatrini, Paola Vacca, Nicola Tumino, et al.
Pigment Cell & Melanoma Research|July 20, 2013
Synergy between enzastaurin doxorubicin in inducing melanoma apoptosisSimona Romano, Giovanna Nappo, Gaetano Calì, et al.
Frontiers in Immunology|February 4, 2022
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor ActivityNicola Tumino, Francesca Besi, Stefania Martini, et al.
British Journal of Haematology|July 28, 2021
MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patientsFederica Rinaldi, Francesco Marchesi, Francesca Palombi, et al.
Pageof 2